These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38126207)

  • 21. Biological therapies in the spondyloarthritides--the current state.
    Braun J; Sieper J
    Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.
    Paramarta JE; De Rycke L; Ambarus CA; Tak PP; Baeten D
    Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug Persistence.
    Flouri ID; Markatseli TE; Boki KA; Papadopoulos I; Skopouli FN; Voulgari PV; Settas L; Zisopoulos D; Iliopoulos A; Geborek P; Drosos AA; Boumpas DT; Sidiropoulos P
    J Rheumatol; 2018 Jun; 45(6):785-794. PubMed ID: 29606666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Juvenile Spondyloarthritis: A Distinct Form of Juvenile Arthritis.
    Weiss PF; Colbert RA
    Pediatr Clin North Am; 2018 Aug; 65(4):675-690. PubMed ID: 30031493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of morbidity and mortality in patients with spondyloarthritis].
    Kiltz U; Sieper J; Braun J
    Z Rheumatol; 2011 Aug; 70(6):473-9. PubMed ID: 21735290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk profile in patients with spondyloarthritis.
    Papagoras C; Markatseli TE; Saougou I; Alamanos Y; Zikou AK; Voulgari PV; Kiortsis DN; Drosos AA
    Joint Bone Spine; 2014 Jan; 81(1):57-63. PubMed ID: 23731637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases.
    Felice C; Pugliese D; Papparella LG; Pizzolante F; Onori E; Gasbarrini A; Rapaccini GL; Guidi L; Armuzzi A
    Expert Rev Clin Immunol; 2018 Sep; 14(9):751-759. PubMed ID: 30118354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current treatment of psoriatic arthritis: update based on a systematic literature review to establish French Society for Rheumatology (SFR) recommendations for managing spondyloarthritis.
    Paccou J; Wendling D
    Joint Bone Spine; 2015 Mar; 82(2):80-5. PubMed ID: 24997741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part II: Specific Management Recommendations.
    Rohekar S; Chan J; Tse SM; Haroon N; Chandran V; Bessette L; Mosher D; Flanagan C; Keen KJ; Adams K; Mallinson M; Thorne C; Rahman P; Gladman DD; Inman RD
    J Rheumatol; 2015 Apr; 42(4):665-81. PubMed ID: 25684768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular morbidity and mortality in patients with spondyloarthritis: A meta-analysis.
    Kim JH; Choi IA
    Int J Rheum Dis; 2021 Apr; 24(4):477-486. PubMed ID: 32969177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.
    Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
    Arthritis Res Ther; 2017 May; 19(1):102. PubMed ID: 28521824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis.
    Frede N; Rieger E; Lorenzetti R; Nieters A; Venhoff AC; Hentze C; von Deimling M; Bartholomä N; Thiel J; Voll RE; Venhoff N
    Front Immunol; 2022; 13():1040725. PubMed ID: 36389682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nonsteroidal anti-inflammatory drugs in the treatment of anterior uveitis associated with spondyloarthritis].
    Razumova IY; Godzenko AA
    Vestn Oftalmol; 2020; 136(6):70-77. PubMed ID: 33084282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis.
    Dubreuil M; Louie-Gao Q; Peloquin CE; Choi HK; Zhang Y; Neogi T
    Ann Rheum Dis; 2018 Aug; 77(8):1137-1142. PubMed ID: 29674321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
    Ward MM; Deodhar A; Akl EA; Lui A; Ermann J; Gensler LS; Smith JA; Borenstein D; Hiratzka J; Weiss PF; Inman RD; Majithia V; Haroon N; Maksymowych WP; Joyce J; Clark BM; Colbert RA; Figgie MP; Hallegua DS; Prete PE; Rosenbaum JT; Stebulis JA; van den Bosch F; Yu DT; Miller AS; Reveille JD; Caplan L
    Arthritis Rheumatol; 2016 Feb; 68(2):282-98. PubMed ID: 26401991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study.
    Stouten V; Pazmino S; Verschueren P; Mamouris P; Westhovens R; de Vlam K; Bertrand D; Van der Elst K; Vaes B; De Cock D
    RMD Open; 2021 Jun; 7(2):. PubMed ID: 34158353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of comorbidities in spondyloarthritis including psoriatic arthritis.
    Scriffignano S; Perrotta FM; De Socio A; Lubrano E
    Clin Rheumatol; 2019 Jan; 38(1):3-10. PubMed ID: 30338414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?
    Webers C; Kiltz U; Braun J; van der Heijde D; Boonen A
    Rheumatology (Oxford); 2023 Jun; 62(6):2139-2146. PubMed ID: 36205588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry.
    Pombo-Suarez M; Sanchez-Piedra C; Garcia-Magallón B; Pérez-Gómez A; Manrique-Arija S; Martín-Doménech R; Colazo M; Campos C; Campos J; Del Pino-Montes J; Arteaga MJ; Cea-Calvo L; Díaz-González F; Gómez-Reino JJ
    Clin Rheumatol; 2021 Oct; 40(10):3979-3988. PubMed ID: 33907904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.